Pieris Pharmaceuticals, Inc. (PIRS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 153.02M |
| Enterprise Value | 95.67M |
| P/E Ratio | -2.82 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.9 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 8.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.24 |
| Return On Equity | -0.48 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | -41.72M |
| Diluted EPS | -3.71 |
Balance Sheet
| Total Cash | 250.58M |
| Total Cash/Share | 17.45 |
| Total Debt | 535,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 21.18 |
| Book Value Per Share | 15.11 |
Price History
| 52-Week Change | -4.96 |
| 52-Week High | 22.32 |
| 52-Week Low | 6.2 |
| Moving Average 50 Days | 16.46 |
| Moving Average 200 Days | 14.03 |
Statistics
| Average Volume | 22,126 |
| Shares Outstanding | 1.32M |
| % Held by Institutions | 0.13 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | April 23, 2024 |
AD
